Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma.

BMC cancer

Volumn 10, Issue , 2010, Pages 489-

  Papazisis, Konstantinos T ^a   Kontovinis, Lukas F ^b   Papandreou, Christos N ^b   Kouvatseas, George ^b   Lafaras, Christos ^b   Antonakis, Evangelos ^b   Christopoulou, Maria ^b   Andreadis, Charalambos ^b   Mouratidou, Despoina ^b   Kortsaris, Alexandros H ^b  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; INDOLE DERIVATIVE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PYRROLE DERIVATIVE; SUNITINIB;

ADULT; AGED; ARTICLE; BLOOD; BONE TUMOR; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BONE NEOPLASMS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INDOLES; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PYRROLES;

MLCS; MLOWN;

EID: 77956474602     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-489     Document Type: Article

References (0)